SpinalCyte Reports Success in Human Clinical Trials of CybroCell

A new cell-based therapy from SpinalCyte could provide a cure for millions of sufferers of degenerative disc disease. The company has released results of phase 1/2 clinical trials, finding an injection of CybroCell led to positive patient outcomes.